TBVI - Tuberculosis Vaccine Initiative
Search...
Home
About us
Mission and strategy
Organisation
Our partners
Financials
Registration and documents
Downloads
Contact
About TB
Facts about TB
Why new vaccines?
Personal stories
Publications
Links
Projects
NEWTBVAC
Pre- and early clinical development
TBTEA
MYCOWALC
ADITEC
TRANSVAC
TBVI Advocacy & Resource Mobilisation
TBVAC
INYVAX
ESI TBVI
News & Agenda
News
Events
Subcribe to our newsletter
Get involved
For everybody
For politicians
For companies
For foundations
Make a donation
Subcribe to our newsletter
Media Centre
Press Releases
Events
Symposium material
TBVI in the media
Video resources
Downloads
Contact
Donate
About us
Mission and strategy
Organisation
Governance Board
Steering Committee
Council of Trustees
Operational Office
Product development team
Clinical development team
Our partners
Financials
Registration and documents
Downloads
Contact
TBVI
»
About us
»
Organisation
»
Product development team
Product Development Team
Dr. Georges Thiry, Chairman
Deputy Director-General Portfolio Management
International Vaccine Institute (IVI)
Seoul, Korea
Read more »
Dr. Mei Mei Ho
Principal Scientist
National Institute for Biological Standards and Control
Hertfordshire, Great Britain
Read more »
Dr. Brijesh Patel
Deputy Manager and Senior Assessor Biologicals and Biotechnology Unit,
MHRA (Medicines and Healthcare products Regulatory Agency)
London, United Kingdom
Read more »
Dr. Eddy Rommel
Managing Director Rommel Consulting Partners
Jodoigne, Belgium
Read more »
Dr. Micha Roumiantzeff
Former Vice President European Vaccine Manufacturers
Brussels, Belgium
Read more »